AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12520257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethylglycine (DMG)
Number of subjects: 5
Study 12520257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 10869758 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (CFRT)
Number of subjects: 13
Study 10869758 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial line measurement variation (RLMV) analysis
Number of subjects: 13
Study 7743619 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 301
Study 7743619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 2209294 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal defecation
Number of subjects: 12
Study 2209294 — intervention group
Group type: COMPARATOR
Intervention: Voluntary prolonged suppression of defecation
Number of subjects: 12
Study 7436551 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine and heparin (DHE‐heparin) medication (2500 IU sodium heparin and 0.5 mg DHE, both given subcutaneously twice daily)
Number of subjects: 125
Study 7436551 — intervention group
Group type: COMPARATOR
Intervention: Low doses of heparin (5,000 IU of sodium heparin given subcutaneously thrice daily)
Number of subjects: 125
Study 31826321 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevascularized hydrogel skin grafts
Number of subjects: 5
Study 31826321 — intervention group
Group type: COMPARATOR
Intervention: Nonvascularized skin grafts (Control)
Number of subjects: 5
Study 31066001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly
Number of subjects: 2932
Study 31066001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 2932
Study 31066001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab combined
Number of subjects: 2932
Study 31066001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2932
Study 31066001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 2932
Study 28814332 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarolaner (Simparica®)
Number of subjects: 162
Study 28814332 — intervention group
Group type: COMPARATOR
Intervention: Spinosad (Comfortis®)
Number of subjects: 162
Study 25398970 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol (n = 42)
Number of subjects: 83
Study 25398970 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist protocol (n = 41)
Number of subjects: 83
Study 25398970 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroticism (assessed at baseline)
Number of subjects: 83
Study 24611240 — intervention group
Group type: EXPERIMENTAL
Intervention: Power BalanceT wristband
Number of subjects: 20
Study 24611240 — intervention group
Group type: COMPARATOR
Intervention: fake silicone wristband
Number of subjects: 20
Study 21373274 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-testing of vaginal pH using test gloves, twice a week from 12th to 32nd week of gestation.
Number of subjects: 149082
Study 21373274 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-testing of vaginal pH).
Number of subjects: 149082
Study 20193613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucocorticoid (INGS) for one year
Number of subjects: 40
Study 20193613 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) for 4 weeks
Number of subjects: 40
Study 20193613 — intervention group
Group type: COMPARATOR
Intervention: Group A (AR patients)
Number of subjects: 40
Study 17579637 — intervention group
Group type: EXPERIMENTAL
Intervention: 2500 mg calcium diet
Number of subjects: 10
Study 17579637 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200S diet
Number of subjects: 10
Study 17579637 — intervention group
Group type: COMPARATOR
Intervention: 400 mg calcium diet
Number of subjects: 10
Study 15514504 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g x kg(‐1) with approximately 1 L of water)
Number of subjects: 10
Study 11754885 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 648
Study 9779081 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% xylitol with 1100 ppm F (NaF)
Number of subjects: 0
Study 9779081 — intervention group
Group type: COMPARATOR
Intervention: 1100 ppm F (NaF)
Number of subjects: 0
Study 9779081 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 0
Study 7942654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant applied for 1 minute before composite application
Number of subjects: 80
Study 7942654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant applied for 2.5 minutes before composite application
Number of subjects: 80
Study 7942654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant applied for 5 minutes before composite application
Number of subjects: 80
Study 7942654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant applied for 10 minutes before composite application
Number of subjects: 80
Study 7942654 — intervention group
Group type: EXPERIMENTAL
Intervention: Two different composites tested
Number of subjects: 80
Study 3365983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive use with alcohol consumption
Number of subjects: 0
Study 3365983 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive use without alcohol consumption
Number of subjects: 0
Study 31621175 — intervention group
Group type: EXPERIMENTAL
Intervention: GreenLight laser photoselective vaporization of the prostate (GL-PVP)
Number of subjects: 119
Study 31621175 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar transurethral vaporization of the prostate (bipolar TUVP)
Number of subjects: 119
Study 30139909 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health patient portal usage
Number of subjects: 0
Study 30139909 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus groups with patients and family members
Number of subjects: 0
Study 30139909 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal usage data
Number of subjects: 0
Study 26464468 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiport approach and large working space
Number of subjects: 15
Study 26464468 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiport approach and intermediate working space
Number of subjects: 15
Study 26464468 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port approach and large working space
Number of subjects: 15
Study 26464468 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port approach and intermediate working space
Number of subjects: 15
Study 26464468 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port approach and small working space
Number of subjects: 15
Study 26464468 — intervention group
Group type: COMPARATOR
Intervention: Single-port surgery
Number of subjects: 15
Study 26464468 — intervention group
Group type: COMPARATOR
Intervention: Multiport surgery
Number of subjects: 15
Study 24275751 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex-specific chest pain characteristics (CPCs)
Number of subjects: 796
Study 23623526 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (detailed dosage not provided)
Number of subjects: 271
Study 20598127 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Internet delivered CBT
Number of subjects: 104
Study 20598127 — intervention group
Group type: COMPARATOR
Intervention: Group CBT
Number of subjects: 104
Study 20598127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Internet CBT
Number of subjects: 104
Study 18166096 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal therapy provided by the study
Number of subjects: 303
Study 18166096 — intervention group
Group type: COMPARATOR
Intervention: Community dental care
Number of subjects: 303
Study 16750060 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating pressure overlay
Number of subjects: 1972
Study 16750060 — intervention group
Group type: COMPARATOR
Intervention: Alternating pressure mattress replacement
Number of subjects: 1972
Study 16750060 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1972
Study 12493134 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treatments for type II diabetes
Number of subjects: 0
Study 10742366 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (8 mg/kg)
Number of subjects: 51
Study 10742366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 8923861 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 28
Study 8923861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1410755 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 16
Study 1410755 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 16
Study 3933894 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 16
Study 3933894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31057315 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard diabetes prevention program (DPP) and faith-enhanced DPP
Number of subjects: 221
Study 29914524 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-year implementation intervention for AOUD treatment delivery
Number of subjects: 2
Study 29914524 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination and psychotherapy for AOUDs
Number of subjects: 2
Study 29914524 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening practices
Number of subjects: 2
Study 29914524 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training and funding for medications
Number of subjects: 2
Study 27431258 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 32
Study 27431258 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 + glibenclamide
Number of subjects: 32
Study 27431258 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 27431258 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 32
Study 24516879 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 μg calcifediol daily
Number of subjects: 35
Study 24516879 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 μg calcifediol weekly
Number of subjects: 35
Study 24516879 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bolus of 140 μg calcifediol
Number of subjects: 35
Study 24516879 — intervention group
Group type: COMPARATOR
Intervention: 20 μg vitamin D3 daily
Number of subjects: 35
Study 24516879 — intervention group
Group type: COMPARATOR
Intervention: 140 μg vitamin D3 weekly
Number of subjects: 35
Study 24516879 — intervention group
Group type: COMPARATOR
Intervention: Single bolus of 140 μg vitamin D3
Number of subjects: 35
Study 22456624 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3 L the day before and 1 L 3h before the procedure (split regimen)
Number of subjects: 336
Study 22456624 — intervention group
Group type: COMPARATOR
Intervention: PEG 4 L the afternoon before colonoscopy (full regimen)
Number of subjects: 336
Study 21047442 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided web-based self-help intervention based on Problem Solving Treatment (PST) for 6 weeks
Number of subjects: 0
Study 21047442 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 0
Study 17937573 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1: Education and offer of contraceptives at the research clinic
Number of subjects: 251
Study 17937573 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2: Education and offer of contraceptives at the research clinic plus a presentation designed to reduce outside pressures to conceive
Number of subjects: 251
Study 17937573 — intervention group
Group type: COMPARATOR
Intervention: Control: Family planning education and referral to an outside clinic for nonbarrier contraceptives
Number of subjects: 251
Study 17937573 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable contraception among HIV-positive women
Number of subjects: 251
Study 15208052 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone, 100 mg/day for 2 consecutive days every 30 days, from months 2-7 of implant use
Number of subjects: 120
Study 15208052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12126343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy along with standard pharmacotherapy
Number of subjects: 10
Study 12126343 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacotherapy alone
Number of subjects: 10
Study 9830944 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoezelen
Number of subjects: 0
Study 9830944 — intervention group
Group type: COMPARATOR
Intervention: Traditional relaxation approach
Number of subjects: 0
Study 7857352 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg administered orally twice a day for 30 days
Number of subjects: 52
Study 7857352 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod
Number of subjects: 52
Study 2510263 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil, 200 micrograms b.d.
Number of subjects: 30
Study 2510263 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate, 1 g t.i.d.
Number of subjects: 30
Study 2510263 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil and Sucralfate
Number of subjects: 30
Study 2510263 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 30
Study 31750726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal Music Therapy (VMT) program for 12 weeks
Number of subjects: 43
Study 31750726 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 43
Study 29703577 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Interaction Project (VIP)
Number of subjects: 546
Study 29703577 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Blocks
Number of subjects: 546
Study 29703577 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 546
Study 28538042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayley‐III Cognitive Composite score
Number of subjects: 77
Study 28538042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayley‐III Motor Composite score
Number of subjects: 77
Study 28538042 — intervention group
Group type: COMPARATOR
Intervention: BSID‐II MDI
Number of subjects: 77
Study 26645517 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q(10) 100 mg daily for 60 days
Number of subjects: 103
Study 26645517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 24274618 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stress management training
Number of subjects: 74
Study 24274618 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 20865874 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 100
Study 20865874 — intervention group
Group type: COMPARATOR
Intervention: No nitrous oxide
Number of subjects: 100
Study 18031592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (3 g Plantago ovata husk and 1 g glucomannan) twice daily (b.i.d.)
Number of subjects: 200
Study 18031592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (3 g Plantago ovata husk and 1 g glucomannan) three times daily (t.i.d.)
Number of subjects: 200
Study 18031592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 18031592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (b.i.d. and t.i.d.)
Number of subjects: 200
Study 15963388 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone (45 mg)
Number of subjects: 192
Study 15963388 — intervention group
Group type: COMPARATOR
Intervention: glimepiride (1 to 6 mg)
Number of subjects: 192
Study 12502980 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental presence during induction of anesthesia (PPIA)
Number of subjects: 80
Study 12502980 — intervention group
Group type: EXPERIMENTAL
Intervention: PPIA plus 0.5 mg/kg oral midazolam
Number of subjects: 80
Study 12502980 — intervention group
Group type: COMPARATOR
Intervention: Control (no PPIA or midazolam)
Number of subjects: 80
Study 11022186 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microgram/kg i.v. ALEX
Number of subjects: 6
Study 11022186 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 microgram/kg i.v. ALEX
Number of subjects: 6
Study 11022186 — intervention group
Group type: COMPARATOR
Intervention: 1.0 microgram/kg i.v. HEX
Number of subjects: 6
Study 11022186 — intervention group
Group type: COMPARATOR
Intervention: 2.0 microgram/kg i.v. HEX
Number of subjects: 6
Study 11022186 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg p.o. ALEX
Number of subjects: 6
Study 11022186 — intervention group
Group type: COMPARATOR
Intervention: 20mg p.o. HEX
Number of subjects: 6
Study 8648837 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 188
Study 8648837 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating mitomycin C and BCG
Number of subjects: 188
Study 1803848 — intervention group
Group type: EXPERIMENTAL
Intervention: PTC chewing gum
Number of subjects: 0
Study 1803848 — intervention group
Group type: COMPARATOR
Intervention: V6 chewing gum
Number of subjects: 0
Study 6849739 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (25 mg oral)
Number of subjects: 4
Study 6849739 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg and 50 mg oral)
Number of subjects: 4
Study 6849739 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline (sustained infusion)
Number of subjects: 4
Study 31924318 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week educational program
Number of subjects: 198
Study 31924318 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 198
Study 31924318 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week educational program (in diabetic patients)
Number of subjects: 198
Study 31924318 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control, in diabetic patients)
Number of subjects: 198
Study 31041925 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational exposure to low levels of ammonia
Number of subjects: 250
Study 31041925 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (office employees)
Number of subjects: 250
Study 29049282 — intervention group
Group type: EXPERIMENTAL
Intervention: REBOOT intervention (motivational interviewing)
Number of subjects: 63
Study 29049282 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (information and referrals)
Number of subjects: 63
Study 27624950 — intervention group
Group type: EXPERIMENTAL
Intervention: REDCap
Number of subjects: 100
Study 27624950 — intervention group
Group type: EXPERIMENTAL
Intervention: SupportScreen
Number of subjects: 100
Study 27624950 — intervention group
Group type: COMPARATOR
Intervention: Paper and pencil
Number of subjects: 100
Study 27624950 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based geriatric assessment
Number of subjects: 100
Study 25140763 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Armor™ (MA; Abbott Nutrition, Columbus, OH)
Number of subjects: 17
Study 25140763 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 17
Study 21946154 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-glucose solution (8% ¹³C‐enriched glucose and 2% milk protein concentrate)
Number of subjects: 8
Study 21946154 — intervention group
Group type: COMPARATOR
Intervention: Glucose only solution
Number of subjects: 8
Study 21946154 — intervention group
Group type: COMPARATOR
Intervention: Noncaloric placebo (water)
Number of subjects: 8
Study 19617584 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus midazolam and/or fentanyl
Number of subjects: 200
Study 19617584 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 200
Study 16651474 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 33357
Study 16651474 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 33357
Study 16651474 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 33357
Study 12631093 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (benazepril 10 mg/day + valsartan 80 mg/day)
Number of subjects: 24
Study 12631093 — intervention group
Group type: COMPARATOR
Intervention: Benazepril (20 mg/day)
Number of subjects: 24
Study 12631093 — intervention group
Group type: COMPARATOR
Intervention: Valsartan (160 mg/day)
Number of subjects: 24
Study 12631093 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 24
Study 12631093 — intervention group
Group type: COMPARATOR
Intervention: Benazepril
Number of subjects: 24
Study 12631093 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 24
Study 12631093 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy, Benazepril, Valsartan
Number of subjects: 24
Study 10958820 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron group (Fe), n = 16
Number of subjects: 47
Study 10958820 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and zinc supplemented group (Fe + Zn), n = 14
Number of subjects: 47
Study 10958820 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented control group (C), n = 17
Number of subjects: 47
Study 8828241 — intervention group
Group type: EXPERIMENTAL
Intervention: Group delivery of structured relapse prevention
Number of subjects: 0
Study 8828241 — intervention group
Group type: COMPARATOR
Intervention: Individual delivery of structured relapse prevention
Number of subjects: 0
Study 1353102 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVAC-1e vaccine
Number of subjects: 36
Study 1353102 — intervention group
Group type: COMPARATOR
Intervention: Control vaccinia virus
Number of subjects: 36
Study 6702866 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (alpha 1-adrenoceptor blockade)
Number of subjects: 0
Study 6702866 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (beta 1-adrenoceptor blockade)
Number of subjects: 0
Study 6702866 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (nonselective beta-adrenoceptor blockade)
Number of subjects: 0
Study 6702866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0